Prospects for Gene-Based Immunopharmacology in Salivary Glands

DOI Web Site Web Site Web Site Web Site ほか1件をすべて表示 一部だけ表示 参考文献79件
  • Yamano Seiichi
    Gene Therapy and Therapeutics Branch,National Institute of Dental and Craniofacial Research,National Institutes of Health,Bethesda,Maryland 20892,USA
  • J. Baum Bruce
    Gene Therapy and Therapeutics Branch,National Institute of Dental and Craniofacial Research,National Institutes of Health,Bethesda,Maryland 20892,USA

書誌事項

タイトル別名
  • Current Perspective. Prospects for Gene-Based Immunopharmacology in Salivary Glands.

この論文をさがす

抄録

The clinical potential of gene transfer is increasing.One likely major application of this emerging biotechnology will be for gene therapeutics, the use of a gene as a drug.Salivary glands provide an unusual but increasingly valuable target site for gene transfer.Studies in animal salivary glands from several laboratories, including our own, have provided proof of this concept.In this review, we provide a background and perspective on possible strategies for gene-based immunopharmacology in salivary glands.We use as a target disease model the autoimmune exocrinopathy Sjögren’s syndrome.

収録刊行物

  • Jpn.J.Pharmacol.

    Jpn.J.Pharmacol. 82 (4), 281-286, 2000

    公益社団法人 日本薬理学会

参考文献 (79)*注記

もっと見る

キーワード

詳細情報 詳細情報について

問題の指摘

ページトップへ